Please login or register first to view this content.
Neurologic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
First Diagnostic Agent Approved to Image Tau Pathology in Patients Being Evaluated for Alzheimer Disease
Rebif Labeling Updated with Pregnancy, Lactation Data
Ofatumumab Bests Teriflunomide in Halting Disease Activity in MS Patients
Trial Assessing Efgartigimod for Myasthenia Gravis Meets Primary End Point
Vesicare LS Approved for Neurogenic Detrusor Overactivity
FDA Grants Fast Track Status to Arimoclomol for ALS
Kynmobi Approved to Treat Off Episodes in Parkinson Disease
Unapproved Cannabidiol, Curcumin Injectables Marketed for Multiple Disorders Recalled
Xcopri Now Available for Partial-Onset Seizures in Adults
Early Metformin Initiation Does Not Appear to Cut Dementia Risk
Bafiertam Gets Final FDA Approval for Multiple Sclerosis
Ongentys Approved as Add-On Treatment for Parkinson Disease
Siponimod Continues to Benefit in Secondary Progressive MS, According to Long-Term Data
FDA to Review Data on Shorter Infusion Time for MS Drug Ocrevus
Vutrisiran Fast-Tracked for Polyneuropathy of hATTR Amyloidosis
Acute Neurologic Deficit Linked to Salicylate Toxicity
Neurologic Effects Seen in a Third of Hospitalized COVID-19 Patients
DEA Deschedules Prescription CBD Drug Epidiolex
